[HTML][HTML] Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis
AS Nagle, S Khare, AB Kumar, F Supek… - Chemical …, 2014 - ACS Publications
Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …
[HTML][HTML] Possibilities and challenges for developing a successful vaccine for leishmaniasis
Leishmaniasis is a vector-borne disease caused by different species of protozoan parasites
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …
Chemotherapy of leishmaniasis: past, present and future
Leishmaniasis is a parasitic disease caused by hemoflagellate, Leishmania spp. The
parasite is transmitted by the bite of an infected female phlebotomine sandfly. The disease is …
parasite is transmitted by the bite of an infected female phlebotomine sandfly. The disease is …
[HTML][HTML] A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries
W Al-Salem, JR Herricks, PJ Hotez - Parasites & vectors, 2016 - Springer
Background Visceral leishmaniasis (VL), caused predominantly by Leishmania donovani
and transmitted by both Phlebotomus orientalis and Phlebotomus martini, is highly endemic …
and transmitted by both Phlebotomus orientalis and Phlebotomus martini, is highly endemic …
Species typing in dermal leishmaniasis
G Van der Auwera, JC Dujardin - Clinical microbiology reviews, 2015 - Am Soc Microbiol
Leishmania is an infectious protozoan parasite related to African and American
trypanosomes. All Leishmania species that are pathogenic to humans can cause dermal …
trypanosomes. All Leishmania species that are pathogenic to humans can cause dermal …
[HTML][HTML] Immune regulation during chronic visceral leishmaniasis
RJ Faleiro, R Kumar, LM Hafner… - PLoS neglected tropical …, 2014 - journals.plos.org
Visceral leishmaniasis is a chronic parasitic disease associated with severe immune
dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine …
dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine …
[HTML][HTML] Post kala-azar dermal leishmaniasis: A threat to elimination program
Leishmaniasis remains a public health concern around the world that primarily affects poor
folks of the developing world spanning across 98 countries with mortality of 0.2 million to 0.4 …
folks of the developing world spanning across 98 countries with mortality of 0.2 million to 0.4 …
[HTML][HTML] Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination
Visceral leishmaniasis (VL) is a severe and often fatal form of leishmaniasis caused by
Leishmania donovani in the Indian sub-continent. Post Kala-azar Dermal Leishmaniasis …
Leishmania donovani in the Indian sub-continent. Post Kala-azar Dermal Leishmaniasis …
[图书][B] Biology of C reactive protein in health and disease
W Ansar, S Ghosh - 2016 - Springer
This book offers a comprehensive study of C-reactive protein (CRP) belonging to the
pentraxin family, including a brief history of CRP, its structure, synthesis and evolution …
pentraxin family, including a brief history of CRP, its structure, synthesis and evolution …
Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects
Human visceral leishmaniasis (VL) continues to be a life-threatening neglected tropical
disease, with close to 200 million people at risk of infection globally. Epidemics and …
disease, with close to 200 million people at risk of infection globally. Epidemics and …